137 related articles for article (PubMed ID: 12366454)
21. Randomized trials in melanoma: an update.
Eggermont AM
Surg Oncol Clin N Am; 2006 Apr; 15(2):439-51. PubMed ID: 16632225
[TBL] [Abstract][Full Text] [Related]
22. Approaches to regional nodes in patients with melanoma.
Deperalta DK; Hoang MP; Tanabe KK
J Clin Oncol; 2014 Mar; 32(9):881-5. PubMed ID: 24516017
[No Abstract] [Full Text] [Related]
23. Sentinel lymph node biopsy in melanoma: Facts and controversies.
Baldwin BT; Cherpelis BS; Sondak V; Fenske NA
Clin Dermatol; 2010; 28(3):319-23. PubMed ID: 20541686
[TBL] [Abstract][Full Text] [Related]
24. Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: the Hospital for Sick Children experience.
Shah NC; Gerstle JT; Stuart M; Winter C; Pappo A
J Pediatr Hematol Oncol; 2006 Aug; 28(8):496-500. PubMed ID: 16912589
[TBL] [Abstract][Full Text] [Related]
25. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
[TBL] [Abstract][Full Text] [Related]
26. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
[No Abstract] [Full Text] [Related]
27. Case records of the Massachusetts General Hospital. Case 2-2007. A 49-year-old woman with a pigmented lesion on the arm.
Thompson JF; Hodi FS; Zembowicz A
N Engl J Med; 2007 Jan; 356(3):285-92. PubMed ID: 17229956
[No Abstract] [Full Text] [Related]
28. [Sentinel lymph node biopsy in melanoma: our experience over 8 years in a universitary hospital].
Bañuelos-Andrío L; Rodríguez-Caravaca G; López-Estebaranz JL; Rueda-Orgaz JA; Pinedo-Moraleda F
Cir Cir; 2015; 83(5):378-85. PubMed ID: 26141108
[TBL] [Abstract][Full Text] [Related]
29. Lessons learned from the Sunbelt Melanoma Trial.
McMasters KM; Noyes RD; Reintgen DS; Goydos JS; Beitsch PD; Davidson BS; Sussman JJ; Gershenwald JE; Ross MI;
J Surg Oncol; 2004 Jul; 86(4):212-23. PubMed ID: 15221928
[TBL] [Abstract][Full Text] [Related]
30. [II. The Latest Treatment Strategy of the Melanoma - The Actual Situation in Japan].
Yoshino K
Gan To Kagaku Ryoho; 2017 Apr; 44(4):302-305. PubMed ID: 28428510
[No Abstract] [Full Text] [Related]
31. [Interferon: therapy in patients with cutaneous malignant melanoma in adjuvant setting].
Wcisło G; Szczylik C
Pol Merkur Lekarski; 2003 Jul; 15(85):5-8. PubMed ID: 14593950
[TBL] [Abstract][Full Text] [Related]
32. High-dose adjuvant interferon therapy for melanoma.
Licata AG
Dermatol Nurs; 1998 Oct; 10(5):334-6. PubMed ID: 9873271
[TBL] [Abstract][Full Text] [Related]
33. Melanoma.
Gershenwald JE
Oncologist; 2001; 6(5):402-6. PubMed ID: 11675517
[TBL] [Abstract][Full Text] [Related]
34. Current management of melanoma: benefits of surgical staging and adjuvant therapy.
McMasters KM; Swetter SM
J Surg Oncol; 2003 Mar; 82(3):209-16. PubMed ID: 12619066
[TBL] [Abstract][Full Text] [Related]
35. A potential predictive marker for response to interferon in malignant melanoma.
Wild PJ; Meyer S; Landthaler M; Hofstaedter F; Bosserhoff AK
J Dtsch Dermatol Ges; 2007 Jun; 5(6):456-9. PubMed ID: 17537037
[TBL] [Abstract][Full Text] [Related]
36. [Detection of residual microscopic disease in melanoma: interest of the sentinel lymph node procedure?].
Mateus C; Thomas M; Robert C
Bull Cancer; 2014 Apr; 101(4):354-7. PubMed ID: 24793626
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulators for skin cancer.
Villa AM; Berman B
J Drugs Dermatol; 2004; 3(5):533-9. PubMed ID: 15552605
[TBL] [Abstract][Full Text] [Related]
38. The role of sentinel lymph-node biopsy in the management of cutaneous melanoma.
Crowson AN; Haskell H
G Ital Dermatol Venereol; 2013 Oct; 148(5):493-9. PubMed ID: 24005142
[TBL] [Abstract][Full Text] [Related]
39. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
40. Current therapy of cutaneous melanoma.
Mays SR; Nelson BR
Cutis; 1999 May; 63(5):293-8. PubMed ID: 10349545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
